Imaging leadership Novarad specializes in full diagnostic imaging suites including NovaPACS Enterprise Imaging and AR-assisted VisAR, presenting a strong value proposition for hospitals seeking integrated imaging workflows and advanced visualization capabilities.

Expansion opportunities Recent product launches such as MammoIQ for breast imaging and the DICOM Route Application indicate a growing product portfolio and cross-sell potential to facilities requiring modular imaging software and better data routing.

Surgical enablement VisAR augmented reality overlays patient anatomy onto the body for surgical planning, creating a compelling upsell angle to surgical centers and IR departments aiming to improve accuracy and outcomes.

Industry engagement Active participation in major conferences (SIR, RSNA, AAOS) signals a strategy to reach radiology, interventional, and orthopedic purchasers; leverage event relationships to accelerate pilots and trials.

Growth potential Revenue range places Novarad in a mid-market tier with a scalable platform; targeting mid-to-large hospitals and health systems with multi-site imaging needs could yield higher ARR through enterprise licenses and managed services.